"Discussions of armed conflict often focus on its most visible consequences: mass casualties, overwhelmed hospitals, and urgent surgical needs. Yet for many civilians the health effects of war unfold less dramatically."
MSF discuss the conflict in Lebanon
https://t.co/vfcSSXz971
Children with diabetes in #Gaza face life-threatening shortages—not only of insulin but also sugar, which is essential to treat dangerous low blood sugar.
Dr. Akihiro Seita, UNRWA Director of Health, highlights how the conflict has turned Gaza into a killing field where even basic medicines and nutrition are out of reach.
Read more: https://t.co/c49FGAGpdf
🚨BREAKING: Oxfam and over 130 organizations demand an immediate end to Israel's deadly distribution scheme, a return to UN-led coordination, and the lifting of the brutal blockade on Gaza.
Read our joint statement 👉https://t.co/OW7PKXGgnj
"[MSF & @T1International ] see an emerging double standard in diabetes care" - @Reuters, on the global phasing out of human insulin pens by @NovoNordisk⬇️
https://t.co/o9UVHRETFU
Today on #WorldDiabetesDay, we’re at @NovoNordisk offices in Johannesburg w/ a message:
📢Resume the supply of insulin pens in South Africa
AND
📢DROP THE PRICE to $1/pen so ALL people living w/ #diabetes can manage their treatment.
Insulin pens shouldn’t be a luxury!
Today is World Diabetes Day. May today mark the start of a significant move towards #equity in access to care. Let's start with insulin pens - which could profitably be made for $1 a pen @novonordisk@sanofi@EliLillyandCo
Today, on #WorldDiabetesDay, we are calling on @novonordisk, @sanofi, and @EliLillyandCo to take urgent action to increase access to diabetes medical tools in LMICs by immediately making insulin pen injection devices available at US$1 per pen (R17,81). https://t.co/Miq2Ig0RET
Today, on #WorldDiabetesDay, we are calling on @novonordisk, @sanofi, and @EliLillyandCo to take urgent action to increase access to diabetes medical tools in LMICs by immediately making insulin pen injection devices available at US$1 per pen (R17,81). https://t.co/Miq2Ig0RET
Why are insulin pens not available in most humanitarian settings?
The prohibitively high costs charged by insulin manufacturers @EliLillyandCo, @novonordisk & @sanofi, despite the much lower estimated production cost of these pens.
Ghassan's journey reveals how vital it is for displaced people living with #diabetes to have access to #insulin with easier delivery.
Read Ghassan’s full story here 👇
https://t.co/XdkYpfKmoB
Amina was also dealing with an abusive & violent husband. Fearing for her 3 young children’s lives, she decided to flee to safety.
With little money & 2 insulin pens, Amina & her children journeyed to Turkey. There, Ehsen had to be hospitalised for over a month.
Most people w/ #diabetes live in low- and middle-income countries, where insulin pens are unaffordable. By #WorldDiabetesDay, @EliLillyandCo, @NovoNordisk & @Sanofi MUST sell them for $1 each! (psst...they cost $0.94 to make WITH space for profit 👀)
https://t.co/a5uTCxP3NM
On 23 Sept, we wrote letters to @NovoNordisk, @Sanofi & @EliLillyandCo asking them to make lifesaving insulin pens available at $1/pen (which costs them $0.94 each to make, btw). Here's what we think of their responses🖍️
https://t.co/i3gjqKCS8L
Doctors Without Borders denounces Israeli ban on @UNRWA 's operations.
It will further undermine people's survival prospects in #Gaza and heavily impact communities in the West Bank.